Damage control resuscitation (DCR) evolved from the concept of damage control surgery. It involves early blood product transfusions using a 1:1:1 ratio of red blood cells, plasma, and platelets to address trauma-induced coagulopathy. It also focuses on immediately arresting hemorrhage, restoring blood volume, and correcting physiological abnormalities like hypothermia and acidosis. DCR can be applied anywhere to critically injured patients. Massive transfusion protocols that guide DCR have been shown to improve survival rates in patients with severe injuries and hemorrhage. While DCR leaves surgical repairs incomplete initially, it buys time to stabilize patients sufficiently to allow for definitive care later.